Standard BioTools Inc. CEO Michael Egholm's Stock Acquisition

On August 1, 2025, Michael Egholm, the President and CEO of Standard BioTools Inc., acquired 3,000,000 shares of the company's common stock through Restricted Stock Units (RSUs). These RSUs vest as follows: 25% on August 1, 2026, and the remaining 75% in three equal annual installments thereafter, contingent on Egholm's continued service. Each RSU entitles him to one share of common stock upon vesting. Following this transaction, Egholm owns a total of 5,736,285 shares, which includes 5,000 shares previously acquired under the company's Employee Stock Purchase Plan. The acquisition was reported in a Form 4 filing with the SEC.